Significant advancements have changed the treatment landscape and clinical practice procedures.
December 2022
Targeted therapies have greatly improved patient outcomes over the past 20 years.
Trends in treatment development involve more targeted, safe, and efficacious therapies.
Specific immune checkpoint inhibitors added to frontline chemotherapy have transformed modern clinical practice.
A focus on developing positive connectivity among colleagues may help support hematology/oncology pharmacists’ efforts to advocate for roles that optimize their personal and institutional value.
Looking to 2023, there remain significant opportunities on the road ahead to improve patient outcomes and patient-centered oncology treatment and care.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Operationalizing Epcoritamab-GemOx in Practice: A Focus on EPCORE NHL-2
2
Under Pressure: A Brief Overview of the Updated Hypertension Guidelines
3
Biosimilar Stivant Shows Noninferior Efficacy and Comparable Safety to Reference Bevacizumab
4
FDA Expands Adalimumab-Aaty For Pediatrics, Adolescents With Rare Inflammatory Conditions
5
